RxDoctor Payments DataLook up a doctor →

Sundeep Das, MD

Interventional Cardiology · Bridgeton, MONPI 1548274749

Payments from drug & device makers

$49,083in general payments, 2019–2025

Across 710 payments — averaging $69.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$18K
  • Angiodynamics, Inc.$18K
  • Novartis$2K
  • Johnson & Johnson$757
  • AstraZeneca$555
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$539
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bard Peripheral Vascular, Inc.5$18,493
Angiodynamics, Inc.8$18,065
Novartis165$1,730
Johnson & Johnson58$757
AstraZeneca28$555
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)41$539
Amgen31$515
E.r. Squibb & Sons, L.L.C.21$507
Merck30$486
Boehringer Ingelheim30$475
Pfizer24$411
Abbott12$399
Corcept Therapeutics16$389
Cardiovascular Systems Inc.9$334
Actelion Pharmaceuticals US, Inc.17$327
Boston Scientific6$326
Edwards Lifesciences5$326
Impulse Dynamics (USA) Inc.6$280
Bayer18$279
Gilead15$256
Alnylam Pharmaceuticals Inc.13$251
Sanofi-aventis U.S. LLC14$249
Vifor Pharma, Inc.16$244
Jenavalve Technology, Inc.1$219
Kiniksa Pharmaceuticals International, PLC8$173
Esperion Therapeutics, Inc.9$155
Daiichi Sankyo Inc.8$153
Novo Nordisk8$152
Regeneron Healthcare Solutions, Inc.10$144
Biotronik Inc.2$142
Cvrx, Inc.2$135
Lexicon Pharmaceuticals, Inc.10$130
Astellas Pharma US Inc2$124
Biosense Webster, Inc.1$122
Philips North America LLC6$119
Kiniksa Pharmaceuticals, Ltd.5$115
Sanofi4$84
United Therapeutics Corporation4$78
Lilly USA, LLC5$77
Lundbeck LLC4$75
Kestra Medical Technology Services, Inc.4$71
Cleerly, Inc.1$70
Medtronic(2 entities)4$67
Scpharmaceuticals Inc.3$56
Reflow Medical Inc1$53
Amarin Pharma, Inc.4$50
Livanova USA, Inc.1$35
Resmed Corp1$34
Itamar Medical Inc1$29
Abiomed1$28
Arbor Pharmaceuticals, Inc.2$27
Chiesi USA, Inc.1$20
Inari Medical, Inc.1$20
Pharmacosmos Therapeutics Inc.1$20
Stryker1$20
Cook Medical LLC1$19
Tactile Systems Technology Inc1$17
Inspire Medical Systems, Inc.1$16
Otsuka America Pharmaceutical, Inc.1$16
Irhythm Technologies, Inc.1$14

How this compares

$49,083 in reported general payments places this provider in the 70th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri

Medicare billing

Part B allowed, 2024
$684,953
Medicare patients
526
Services billed
9,795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Bridgeton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →